Anatomic tests like coronary artery calcium scans primarily serve to guide the aggressiveness of medical therapy, such as initiating statins or PCSK9 inhibitors.

“And what I tell people is that the results of these anatomic tests that we might do are really about answering one question, which is, how aggressive should we be with our medical therapy? And what they are, they are triggers for basically saying yes or no to statins or yes or no to statins and PCS kinetamines.”